COMMUNIQUÉS West-GlobeNewswire

Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference
16/03/2026
EAGLE, Idaho, March 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
16/03/2026
-- Four substudies did not meet pre-specified primary endpoints -- -- Post hoc analyses show setmelanotide achieved statistically significant BMI reductions in patients with obesity due to a heterozygous variant of the [...]
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
16/03/2026
BRISBANE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
16/03/2026
SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it has commenced an [...]
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
16/03/2026
Clinical update on track for Q2 2026 for Phase 2 trial of silevertinib in patients with non-classical EGFRm NSCLC, including preliminary DOR and PFS data in frontline setting Company is preparing to initiate a [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
16/03/2026
RADNOR, Pa., March 16, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic [...]
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
16/03/2026
CRANFORD, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“ Enzon ” or the “ Company ”) today announced that it has extended the expiration date for the exchange offer by the Company [...]
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
16/03/2026
Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness – CUE-401 is the Company’s lead asset for the treatment of autoimmune and inflammatory diseases Appointed industry veteran [...]
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
16/03/2026
Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and remains on track for [...]
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
16/03/2026
Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing [...]
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
16/03/2026
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 IRVINE, California – March 16, 2026 ( [...]
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions
16/03/2026
With the addition of 2,176 NVIDIA Blackwell GPUs, Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totaling more than 3,500 GPUs. The new computational infrastructure supports [...]
CMR Surgical Advances Physical AI to Support the Future of Robotic Surgery with NVIDIA
16/03/2026
Cambridge-based surgical robotics company contributes majority of surgical data to world’s largest open healthcare robotics dataset Cambridge, UK and San Jose, California – 16 March 2026, CMR Surgical (“CMR”), the [...]
Tobias Burkhardt’s Paretofit Reports 98.1% Success Rate Across 169 Entrepreneur Coaching Engagements
16/03/2026
Paretofit, founded by Tobias Burkhardt, reports a 98.1% documented success rate across 169 completed coaching engagements with entrepreneurs, founders, and self-employed professionals in the DACH region. Köln, NORDRHEIN [...]
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
16/03/2026
Company to Report Fourth Quarter Financial Results and Provide Strategic Update on March 31, 2026 ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global [...]
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
16/03/2026
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference. Iradimed’s CEO, Roger Susi, and CFO, Jack Glenn, will [...]
Annual General Meeting in ALK-Abelló A/S held on 16 March 2026
16/03/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): ALK-Abelló A/S held its Annual General Meeting on 16 March 2026. The Annual General Meeting transacted the following business: Approval of the annual report 2025 and discharge [...]
Qolab Announces John Martinis Prize as Momentum Builds for Scalable Quantum Hardware
16/03/2026
Debuting at APS Global Physics Summit with Quantum Machines and IQCC, Alongside New Collaborations, Education Programs, and Hiring Expansion DENVER, March 16, 2026 (GLOBE NEWSWIRE) -- Qolab today announced the launch of [...]
Completion of Share Buy-back Program
16/03/2026
Company Announcement COPENHAGEN, Denmark; March 16, 2026 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on March 13, 2026. On February 17, 2026, Genmab announced the initiation [...]

Pages